Clinical Trial Update: CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cebranopadol to extended-release morphine in patients with chronic moderate to severe cancer-related pain; trial terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain
• Neoplasms

Drugs mentioned

• Cebranopadol (cebranopadol)
• Morphine (morphine)

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Pain, Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2019-12-30